Swedbank’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $76.8M | Buy |
|
|||||
|
2025
Q2 | $63.3M | Buy |
|
|||||
|
2025
Q1 | $47.5M | Buy |
|
|||||
|
2024
Q4 | $1.13M | Sell |
|
|||||
|
2024
Q3 | $1.61M | Hold |
|
|||||
|
2024
Q2 | $1.93M | Hold |
|
|||||
|
2024
Q1 | $1.93M | Buy |
|
|||||
|
2023
Q4 | $954K | Hold |
|
|||||
|
2023
Q3 | $815K | Hold |
|
|||||
|
2023
Q2 | $683K | Hold |
|
|||||
|
2023
Q1 | $733K | Hold |
|
|||||
|
2022
Q4 | $865K | Hold |
|
|||||
|
2022
Q3 | $769K | Hold |
|
|||||
|
2022
Q2 | $706K | Hold |
|
|||||
|
2022
Q1 | $679K | Hold |
|
|||||
|
2021
Q4 | $613K | Hold |
|
|||||
|
2021
Q3 | $695K | Hold |
|
|||||
|
2021
Q2 | $705K | Hold |
|
|||||
|
2021
Q1 | $704K | Buy |
|